Zeng, J.; Sanders, A.J.; Ye, L.; Hargest, R.; Ruge, F.; Jiang, W.G.
EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance. Int. J. Mol. Sci. 2022, 23, 15232.
https://doi.org/10.3390/ijms232315232
AMA Style
Zeng J, Sanders AJ, Ye L, Hargest R, Ruge F, Jiang WG.
EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance. International Journal of Molecular Sciences. 2022; 23(23):15232.
https://doi.org/10.3390/ijms232315232
Chicago/Turabian Style
Zeng, Jianyuan, Andrew J. Sanders, Lin Ye, Rachel Hargest, Fiona Ruge, and Wen G. Jiang.
2022. "EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance" International Journal of Molecular Sciences 23, no. 23: 15232.
https://doi.org/10.3390/ijms232315232
APA Style
Zeng, J., Sanders, A. J., Ye, L., Hargest, R., Ruge, F., & Jiang, W. G.
(2022). EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance. International Journal of Molecular Sciences, 23(23), 15232.
https://doi.org/10.3390/ijms232315232